Option Care Health, Inc. (NASDAQ:OPCH) Shares Bought by Jennison Associates LLC

Jennison Associates LLC raised its holdings in shares of Option Care Health, Inc. (NASDAQ:OPCH - Free Report) by 26.6% during the third quarter, according to its most recent filing with the SEC. The firm owned 472,274 shares of the company's stock after purchasing an additional 99,139 shares during the period. Jennison Associates LLC owned 0.28% of Option Care Health worth $14,782,000 at the end of the most recent reporting period.

Several other large investors have also modified their holdings of the business. UMB Bank n.a. increased its holdings in Option Care Health by 937.5% during the third quarter. UMB Bank n.a. now owns 830 shares of the company's stock valued at $26,000 after buying an additional 750 shares during the period. GAMMA Investing LLC increased its holdings in shares of Option Care Health by 110.6% in the 3rd quarter. GAMMA Investing LLC now owns 897 shares of the company's stock valued at $28,000 after acquiring an additional 471 shares during the period. Whittier Trust Co. of Nevada Inc. raised its position in shares of Option Care Health by 3,362.8% in the 3rd quarter. Whittier Trust Co. of Nevada Inc. now owns 1,489 shares of the company's stock worth $47,000 after acquiring an additional 1,446 shares in the last quarter. Blue Trust Inc. lifted its stake in shares of Option Care Health by 14.8% during the 2nd quarter. Blue Trust Inc. now owns 2,931 shares of the company's stock worth $81,000 after purchasing an additional 377 shares during the last quarter. Finally, International Assets Investment Management LLC lifted its stake in shares of Option Care Health by 3,029.7% during the 3rd quarter. International Assets Investment Management LLC now owns 2,848 shares of the company's stock worth $91,000 after purchasing an additional 2,757 shares during the last quarter. Institutional investors own 98.05% of the company's stock.

Analyst Ratings Changes

A number of equities analysts have commented on OPCH shares. JMP Securities boosted their target price on shares of Option Care Health from $36.00 to $37.00 and gave the stock a "market outperform" rating in a report on Monday, September 30th. The Goldman Sachs Group cut shares of Option Care Health from a "buy" rating to a "neutral" rating and decreased their target price for the company from $38.00 to $27.00 in a research report on Monday, November 4th. Truist Financial lowered their target price on shares of Option Care Health from $41.00 to $34.00 and set a "buy" rating for the company in a research note on Friday, November 1st. Jefferies Financial Group downgraded Option Care Health from a "buy" rating to a "hold" rating and reduced their price target for the stock from $38.00 to $26.00 in a research report on Thursday, October 31st. Finally, Barrington Research lowered their price objective on Option Care Health from $40.00 to $32.00 and set an "outperform" rating for the company in a research report on Thursday, October 31st. Three investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the company's stock. According to data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and an average target price of $30.83.

Insider Buying and Selling

In other news, Director Harry M. Jansen Kraemer, Jr. purchased 43,000 shares of the stock in a transaction that occurred on Friday, November 8th. The shares were purchased at an average cost of $22.54 per share, with a total value of $969,220.00. Following the completion of the acquisition, the director now owns 326,334 shares of the company's stock, valued at approximately $7,355,568.36. This represents a 15.18 % increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. 0.64% of the stock is owned by corporate insiders.

Option Care Health Stock Performance

OPCH traded up $0.64 on Friday, reaching $23.13. 1,638,831 shares of the stock were exchanged, compared to its average volume of 3,016,309. The company has a debt-to-equity ratio of 0.77, a current ratio of 1.73 and a quick ratio of 1.32. The company's 50-day moving average price is $27.62 and its 200 day moving average price is $29.10. The firm has a market capitalization of $3.94 billion, a PE ratio of 19.44, a PEG ratio of 2.33 and a beta of 1.32. Option Care Health, Inc. has a fifty-two week low of $21.39 and a fifty-two week high of $34.63.

Option Care Health Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.